Voya Investment Management LLC Harvard Bioscience Inc Transaction History

Voya Investment Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 06, 2024	BUY	$4.02 - $5.39 $58,314 - $78,187	14,506 New	14,506 $61,000
Q1 2024 May 15, 2024	SELL	$4.02 - $5.39 $10,693 - $14,337	-2,660 Reduced 15.5%	14,506 $61,000
Q3 2023 Nov 14, 2023	BUY	$4.0 - $5.82 $4,524 - $6,582	1,131 Added 7.05%	17,166 $73,000
Q2 2023 Aug 14, 2023	BUY	$4.19 - $6.16 $67,186 - $98,775	16,035 New	16,035 $88,000
Q2 2022 Aug 15, 2022	SELL	$3.28 - $6.42 $73,918 - $144,681	-22,536 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.16 - $7.14 $33,730 - $46,674	6,537 Added 40.86%	22,536 $140,000
Q4 2021 Feb 14, 2022	SELL	$6.37 - $8.18 $4,446 - $5,709	-698 Reduced 4.18%	15,999 $113,000
Q2 2021 Aug 16, 2021	SELL	$5.44 - $8.4 $11,157 - $17,228	-2,051 Reduced 10.94%	16,697 $139,000
Q4 2020 Feb 16, 2021	BUY	$3.0 - $4.5 $24,897 - $37,345	8,299 Added 79.42%	18,748 $80,000
Q3 2020 Nov 16, 2020	BUY	$2.75 - $4.2 $28,734 - $43,885	10,449 New	10,449 $31,000
Q2 2019 Aug 14, 2019	SELL	$1.93 - $4.59 $28,930 - $68,804	-14,990 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$4.2 - $5.95 $62,958 - $89,190	14,990 New	14,990 $80,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.